Updated Preliminary Data from SMA FIREFISH Program in Type 1 Babies Presented at the CureSMA Conference
- risdiplam (RG7916) is well tolerated at all dose levels with no drug-related safety findings -
Page (1) of 1 - 06/16/18||
This article is no longer available,but here are some related topics.
All Rights Reserved